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Abstract
It is known that 30–40 % of patients with peritoneal endometriosis suffer from infertility. Half of the patients 
with endometriosis are identified point mutation in NAT2 – gene, which plays an important role in the acetylation of 
aromatic and heterocyclic amines, in the accumulation of endotoxins, activation of free radical oxidation, impaired mi-
crocirculation. These factors involve the use of methods of gemapheresis which have detoxification, the blood rheology 
corrective and immune corrective effects. 
The purpose of this study was to evaluate the efficacy of therapeutic plasma exchange in treatment of patients 
with peritoneal form of endometriosis, infertility and point mutations in the gene NAT2. 
The study included 140 patients with infertility, peritoneal form of endometriosis and point mutations in the gene 
NAT2. All patients are performed laparoscopy, coagulation foci of endometriosis. In the following 93 (66.4 %) patients 
were treated with a the course of therapeutic plasmapheresis using the apparatus «PCS-2» with the removal of 20–25 % 
the volume of circulating plasma with replacement plasma of crystalloid and colloid solutions. Before treatment were 
shown the signs of endotoxemia, activation of oxidative stress. After treatment with the use of plasmapheresis was re-
vealed the significant reduction of endogenous intoxication parameters and oxidative stress. Also is noted the increase in 
the pregnancy rate, both independently and in IVF programs, especially during the first 3 months after treatment. The 
findings suggest that the efficiency of the proposed comprehensive treatment techniques (laparoscopy and subsequent 
course of therapeutic plasmapheresis) of patients with peritoneal endometriosis and infertility and with point mutations 
in the gene NAT2. The use of plasmapheresis is pathogenetically justified in patients of the studied group. 
Keywords: infertility, peritoneal endometriosis, point mutations in the gene NAT2, endotoxicosis, oxidative 
stress, therapeutic plasmapheresis, pregnancy.
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1. Introduction
Infertility is an important medical and social problem. One of the most frequent causes of re-
productive function disorder (30–40 %) is endometriosis. Half of the patients with endometriosis are 
identified to have point mutation in NAT2 gene. NAT2 gene product arylamine-N-acetyltransferase-2 
is known to play an important role in the acetylation of aromatic and heterocyclic amines. That is 
why the disorder of its function, caused by encoding gene polymorphism, leads to accumulation of 
endotoxins, which, in its turn, strengthens process of free-radical oxidation in a cell. The impor-
tance of oxidative stress in case of endometriosis also has been proved on the basis of studying of 
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specific markers that comes with endotoxicosis, activation of lipid peroxidation, impaired micro-
circulation. These factors involve the usage of gemapheresis methods which have detoxification, 
the blood rheology corrective and immune corrective effects. Within recent years the methods 
of gemapheresis (or efferent methods) have been used in therapy of more than 200 different dis-
eases [1–9], including obstetrics and gynecology. Thus, the efficiency of one of the gemapher-
esis method – plasmapheresis in complex therapy of placental insufficiency, after myomectomy 
and metrectomy, during climacteric syndrome, chronic pelvic inflammatory diseases and during 
preparation for assisted reproductive technology (ART) programs is proved [10–15]. The research-
es recommend including plasmapheresis to the complex of rehabilitation action after laparoscopic 
corrective-plastic operation in tubal and peritoneal infertility [16].
Plasmapheresis is used in assisted reproductive technology programs for women with tubal 
and peritoneal infertility to improve the blood rheological properties, microcirculation, to reduce 
the active influence of steroid hormones on the blood clotting in multifollicular ovarian stimulation 
process, to increase the stability of vascular endothelial permeability, to reduce endotoxemia level, 
to remove immune complexes, antiphospholipid antibodies and antibodies to chorionic gonadotropin 
from blood system, and for treatment and prevention of acute herpetic and cytomegalovirus infection, 
reduction of the pill burden on the organism and prevention of ovarian hyperstimulation syndrome.
However, up to the present moment, the issue of the pathogenetically substantiated use of plas-
mapheresis in treatment of patients with infertility and peritoneal form of endometriosis and point mu-
tations in the gene NAT2 is not yet fully studied. NAT2 gene product arylamine-N-acetyltransferase-2 
is known to play an important role in the acetylation of aromatic and heterocyclic amines. That is 
why the disorder of its function, caused by encoding gene polymorphism, leads to accumulation of 
endotoxins, which, in its turn, strengthens process of free-radical oxidation in a cell [17]. The im-
portance of oxidative stress in case of endometriosis also has been proved on the basis of studying 
the specific markers [18]. 
Taking into account that the detoxifying effect of plasmapheresis is pronounced not only 
because of mechanical removal of bacteria and their toxins, inflammatory mediators, metabolic 
products, components of destroyed and necrotic changed cells, but also because of the stimulation 
of organs and body systems, responsible for binding, inactivation and elimination of endo- and 
exotoxins, as well as for reducing free radical reactions of lipid peroxidation, it can be assumed 
that its usage will have a positive impact on the entire detoxification systems of the body, as well 
as on antioxidant protection, and, therefore, will improve the results of patients with infertility and 
peritoneal endometriosis treatment. 
The purpose of this study was to evaluate the efficacy of therapeutic plasma exchange in 
treatment of patients with peritoneal form of endometriosis, infertility and point mutations in the 
gene NAT2. 
2. Materials and methods
The study included 140 patients with infertility, peritoneal form of endometriosis, verified 
by the laparoscopy, and point mutations in the gene NAT2. All patients were performed coagula-
tion foci of endometriosis during laparoscopy, salpingoovariolisis, fimbrioplasty (on therapeutic 
grounds). Then all patients were divided into 2 groups: the main group included 93 (66.4 %) wom-
en, who underwent a course of plasmapheresis (2-nd stage of complex treatment) in the next cycle 
after laparoscopy; the comparison group included 47 (33.6 %) patients who did not experience 
efferent methods of treatment. Considering the current recommendations of the European Society 
of Human Reproduction on the ineffectiveness of hormone replacement therapy and biologically 
active dietary supplements with regard to increasing fertility after surgery for endometriosis, it 
was decided not to prescribe any drugs. The course of therapeutic plasmapheresis (PA) for pa-
tients of the main group was held in the first phase of the menstrual cycle starting on 5th or 6th day 
and included 3 sessions of PA with an interval of 2–4 days. The procedure was carried out in the 
PCS2 device made by «Haemonetics» (USA). The assembly of line system was carried out under 
aseptic conditions, immediately before the procedure. SDA-A solution (acidic dextrose) supplied 
automatically in a ratio of 1/12 to the blood was used as anticoagulant. Before starting the proce-
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dure the patient was intravenously administered with heparin in an amount of 25 units for kg/body 
weight. The therapeutic plasmapheresis was carried out with the blood flow to the device at speed 
of 25–40 ml per minute, depending on the catheter capacity and the vein ability. The spin speed 
of PCS2 centrifuge is 7500 rpm, plasma was removed at speed of 15–30 ml per min depending on 
speed of blood flow supply. 
Simultaneously with the blood sampling and removal of plasma, it was produced the plasma 
replacement by crystalloid (saline 0.9 %) and colloidal (hydroxyethylated starch solutions of 6 % or 
10 % with the molecular weight of 130/04 or 200/04) solutions at a ratio of 1:1.5 by volume of exfu-
sion in the device automatic mode. In case of low albumin (less than 60 g/l) 10 % albumin solution 
(100 ml) was included in the plasma replacement procedure.
To calculate the volumes of circulating plasma and blood and quantity of plasma to remove, 
mathematical calculation program, based on certain anthropometric patient data and some physi-
ological constants, was used. The circulating blood volume (CBV) was counted considering body 
weight, height, constitutional type based on Moore method. 
CBV=М×Bq,
where М is body weight in kg; Bq is the blood quantity in ml per kg of body weight (depends on 
body build of a woman and is from 55 to 70 ml/kg).
Then the hematocrit, that is triple hemoglobin level, was calculated (h %). 
Ht=Hn×3, 
where Ht is hematocrit in %; Hn is hemoglobin contents in h %.
Then on the base of calculated CBV and hematocrit, CPV (circulating plasma volume) was 
counted:
CPV=CBV×(100 % – Ht).
Using estimated CPV the planning percentage of plasma to remove (P) was calculated, add-
ing to it 5 % for additionally administrated anticoagulant solution into the affluent line, the most 
part of which is removed with plasma, and got the planning removing plasma quantity (RPQ):
RPQ=CPV×P×(100 %+5 %)=CPV×P×1.05.
Criteria for inclusion:
1. Patients with infertility, peritoneal form of endometriosis, verified by the laparoscopy.
2. Age: 20–39.
3. Normal ovarian reserve (FSH indicators are less than 8 IU/l, Anti-Mullerian Hormone is 
more than 2 uh/ml and quantity of antral follicles is more than 10 in each ovary on the 2nd–3rd day 
of the cycle).
4. Presence of 3 or more point mutations in the gene NAT2. 
Criteria for exclusion:
1. Patients with uterine myoma, benign ovarian tumors, hydrosalpinx, malformations of 
female genitalia.
2. Presence of a somatic pathology associated with the presence of point mutations in the 
gene NAT2 (psoriasis, neurodegenerative diseases, lung and bladder disease).
3. Patients with endocrine factor of infertility.
Methods:
1. General clinical examination
Making anamnesis the special attention was paid to menstrual and reproductive functions of 
patients, outcome of previous pregnancies and its complications. There were estimated frequency 
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of infectious diseases in childhood, the nature of inflammation, there were got data of accompany-
ing extragenital pathology and experienced surgeries, trauma, hereditary diseases. 
2. Genetic study 
Presence of NAT2 gene polymorphism was studied at the laboratory on the base of N. F. Ga-
maleya Research Institute of Epidemiology and Microbiology of Ministry of Healthcare and Social 
Development of the Russian Federation. All patients gave informed consent for the use of the blood 
for the research. 
The material for this study was DNA samples separated from peripheral blood leukocytes of 
the patients. As a preservative one the 1 ml of 0.5 M EDTA pH 8.0 was used. 
3. Quantitative assessment of the level of endogenous intoxication (endotoxic index (EI), the 
molecules of average weight (AWM)) and quantitative assessment of the level of oxidative stress 
(malonaldehyde (МА), superoxide dismutase (SOD), total antioxidant activity (TAA)) before and 
after plasmapheresis.
4. Statistical data manipulation 
To analyze the results statistical computer programs SPSS (version 10.0.7) and Statistica (Ver-
sion 6.0) for Windows were used. Differences between groups were considered to be reliable at р<0.05.
3. Results of research
Results of the clinical-anamnestic and genetic characteristics of patients with infertility, peri-
toneal endometriosis and point mutations in the gene NAT2 have been already represented [19]. The 
findings draw attention to the high frequency of the respiratory and genitourinary system chronic 
diseases, infectious, autoimmune and allergic skin disorders; burdened oncologic and allergological 
anamnesis of this patients group. During the results of clinical-anamnestic study estimation it was 
revealed some hemoglobin decrease rates among almost all patients: its average index was 110±3 g/l 
(N=120–140 g/l). The total number of leukocytes of 93 % of these patients came close to the upper 
limit of normal rate: average 8.4±0.6×109\l (N=4.0–9.0×109l), and leukogram showed that 78 % of 
patients have imperceptible shift to the left (stabed – 7.7±0.6 %, segmented – 45.2±0.3 %). This can 
be associated with impaired metabolism of xenobiotics caused by the point mutations in the NAT2 
gene and endogenous intoxication [20].
According to the results of research, infertility treatment of the patients with peritoneal 
endometriosis and point mutations in the gene NAT2 is less efficient than that of patients who do 
not have mutations [21]. It was found out that the group of patients with infertility and peritoneal 
endometriosis was non-uniform in detoxification system condition and pro- antioxidant balance at 
the system level. Detected changes are associated with the presence or absence of point mutations 
in the gene NAT2: their presence is marked by increase of the endogenous intoxication level and 
prooxidant shift. This cohort of patients can be referred to the group of poor prognosis in relation 
to the frequency of intrauterine pregnancy occurrence after treatment [22].
In order to estimate the influence of efferent methods treatment on the endogenous intox-
ication level and oxidative stress indexes, there were tested endotoxin index (EI), the index of 
molecules of average weight (AWM) and quantitative assessment of malondialdehyde level (MA), 
superoxide dismutase (SOD), total antioxidant activity (TAA)) of patients with infertility, perito-
neal endometriosis and point mutations in the gene NAT2 before and after plasmapheresis (PA).
The changes of endogenic toxicosis and oxidative stress indexes before and after plasma-
pheresis of patients with peritoneal form of endometriosis, infertility and point mutations in the 
gene NAT2 are represented in Table 1.
After plasmapheresis procedure there were noticed the reliable decrease of molecules of 
average weight concentration (AWM) (р<0.05). Analysis of endotoxin index showed the increase 
of the patients’ EI during complex treatment with usage of plasmapheresis (р<0.05).
The contrastive analysis of malondialdehyde, superoxide dismutase and total antioxidant 
activity concentration in the patients’ blood was used to estimate the oxidative stress indexes. 
The results represented in the table show that in the main group of patients, who experienced 
plasmapheresis procedure, there were registered a significant decrease of MA concentration (from 
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4.7±0.39 to 2.5±0.29 mcMol/l) (р<0.05). Superoxide dismutase and total antioxidant activity levels 
increased up to 23.4 and 14.8 % respectively (р<0.05).
The further examination have been carried out for 12 months to estimate the remote results 
of complex treatment of infertility of patients with peritoneal form of endometriosis and point mu-
tations in the gene NAT2. The data are represented in Table 2.
Table 1
Changes of endogenic toxicosis and oxidative stress indexes before and after plasmapheresis of 
patients with peritoneal form of endometriosis, infertility and point mutations in the gene NAT2
Index
Main group (n=93)
Before plasmapheresis After plasmapheresis
AWM 254nm, c. u. 0.27±0.04 0.21±0.03*
AWM 280nm, c. u. 0.32±0.04 0.26±0.02*
EI 254 nm 3.57±0.99 4.9±0.76*
EI 280 nm 3.18±0.97 4.1±0.49*
Malondialdehyde (mcMol/l) 4.7±0.39 2.5±0.29*
Superoxide dismutase (Units/gHb) 1210±63.05 1711±68.12*
Total antioxidant status (mMol/l) 1.43±0.23 1.91±0.19*
Note: * – reliable difference in comparison with indexes before the therapeutic plasmapheresis procedure (р<0.05)
Table 2
Remote results of complex treatment of patients with peritoneal form of endometriosis, 
infertility and point mutations in the gene NAT2. In (%)
Index
Research group (n=140)
Less than 3 months 3−6 months 6−12 months
Main group
(n=93)
Comparison 
group
(n=47)
Main group
(n=93)
Comparison 
group
(n=47)
Main group
(n=93)
Comparison 
group
(n=47)
Independent  
pregnancy
11
(11.8 %)
4*
(6.4 %)
6
(6.5 %)
2
(4.3 %)
6
(6.5 %) 0
Pregnancy after 
IVF programs
15
(16.1 %)
5*
(8.5 %)
8
(8.6 %)
1*
(2.1 %)
3
(3.2 %)
1
(2.1 %)
Total of progress-
ing intra-uterine 
pregnancy
26
(27.9 %)
9*
(19.1 %)
14
(15.05 %)
3*
(6.4 %)
9
(9.7 %)
1*
(2.1 %)
Missed abortion
2
(2.1 %)
4*
(8.5 %)
2
(2.1 %) 0
1
(1.1 %)
1*
(2.1 %)
Ectopic pregnancy 2(2.1 %)
1
(2.1 %) 0
1
(2.1 %)
1
(1.1 %) 0
Note: * – reliable difference in comparison with the main group (р<0.05)
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Analysis of obtained results showed that the highest frequency of pregnancies in both 
groups (27.9 % – in mail group and 19.1 % – in comparison group) was observed during the 
first 3 months after treatment and it significantly decreased after 6 months of examination that 
is in accordance with the literature data [23]. However, in the group of patients who did not get 
complex treatment with usage of efferent methods, the frequency of independent pregnancies as 
well as occurrence of pregnancies after IVM programs was reliably lower (by 6.5 and 1.5 times 
respectively) during 6–12 months, than that of the main group. Calls attention to itself the fact, 
that the quantity of missed abortions during the first three months among the patients, who did 
not experience therapeutic plasmapheresis, was by 4 times higher than that of the main group 
(р<0.05) and reached 8.5 %. 
In accordance with the literature data one of the reasons of missed abortion during the first 
trimester is trophoblast extensive injuries, caused by oxidative stress and disorder of pro- antiox-
idant systems [2]. It should be said that during the last years therapeutic plasmapheresis has been 
widely used in habitual non-carrying of pregnancy clinic as pregravid preparation and as a thera-
peutic factor during gestation [4, 21, 24].
The quantity of patients with ectopic pregnancy did not differ significantly in studied groups. 
Data analysis revealed the increase of pregnancy frequency by 2 times during 3–6 months 
and by 4 times during 6–12 months in the main group in comparison with patients, who did not 
get complex treatment. However, the efficiency of IVM programs in the main group of patients 
significantly decreased in 6 months after treatment from 8.6 to 3.2 % that can be caused by short-
term effect of complex treatment with usage of therapeutic plasmapheresis and following recurrent 
changes of oxidative stress condition.
4. Discussion 
In the end of the 90-s (XX century) it was revealed that genetically predetermined detoxifi-
cation system failure can become a risk factor for the endometriosis development. The researchers 
proved that gene of glutathione S-transferase M1 (GST), associated with the second phase of detox-
ification, plays a significant role in the pathogenesis of this disease [9]. More modern studies, in-
cluded experiments on rhesus macaques, proved the importance of arylamine N- acetyltransferase 
gene (NAT-2) polymorphism in endometriosis development [25].
It is proved that allelic variants of NAT2 gene are characterized by different activity of 
the enzyme N-acetyltransferase. Depending on this, the respective carriers of allelic variants 
are divided into «fast», «intermediate» and «slow» acetylators [9]. The studied point mutations 
lead to the formation of “slow acetylation phenotype», which, according to literature data, help 
to reduce levels of the enzyme N-acetyltransferase, slowing the conversion of acetyl-CoA to 
acetoacetyl-CoA [26]. Such changes lead to xenobiotic metabolism disorder that increases en-
dogenous intoxication level. 
In addition, nowadays researchers study oxidative stress markers in follicular fluid and 
blood serum of patients with infertility and endometriosis; these researches are associated with 
the search for mechanisms that lead to a decrease in fertility in natural conception, as well as in 
conception when assisted reproductive technologies are used, including cases of ovicells’ poor 
quality. The decrease of antioxidant activity was shown among the patients with endometriosis and 
infertility that affects both folliculogenesis and the quality of oocytes and embryos [27]. Changes 
in multi-component antioxidant systems function and in regulation of a certain level of lipid perox-
idation cause the disorder in the normal functioning of cells, including endometrial ones, that can 
be a precipitating factor in the progression and dissemination of endometriosis [28–30]. 
It is proved that the particularities of NAT2 gene polymorphism are associated with the effi-
ciency of the treatment of patients with infertility and peritoneal endometriosis and influence on the 
certain results. It is revealed that the frequency of NAT2 gene point polymorphism presence (с.341Т>C, 
c.481C>T, c.590G>A and c.803A>G) is by 3 times lower among patients with peritoneal endometriosis 
who got pregnant as a result of treatment, than that of those who did not get pregnant. Patients, who do 
not have point mutations in the gene NAT2 can be referred to the group of good prognosis [31]. 
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5. Conclusions
Thus, the results of the studies showed the effectiveness of plasmapheresis as a method for 
stabilizing the oxidative status of the system and its positive role, from clinical view, for patients 
with infertility and peritoneal endometriosis. After the complex treatment in this group of patients 
it was exposed significant increase in the number of intrauterine pregnancies occurrence (both 
independent and in the course of assisted reproduction programs), as well as decrease of missed 
abortion number. 
By all appearances, this effect is relatively short-termed and allows create some “reproduc-
tive window” of fertility improvement in the group of women with point mutations in NAT2 gene 
and impaired detoxification system (a group of poor prognosis in relation to the uterine pregnancy 
occurrence), which explains the best results during 3 months after treatment. 
The developed method of the differentiated approach to care of patients with infertility and 
peritoneal endometriosis considering particularities of NAT2 gene polymorphism allows improving 
significantly remote results of treatment (uterine pregnancy occurrence and its prolongation).
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